Compounds > 2-2-bis(hydroxymethyl)-1-azabicyclo(2-2-2-)octan-3-one

2-2-bis(hydroxymethyl)-1-azabicyclo(2-2-2-)octan-3-one and Head-and-Neck-Neoplasms

2-2-bis(hydroxymethyl)-1-azabicyclo(2-2-2-)octan-3-one has been researched along with Head-and-Neck-Neoplasms* in 1 studies

Reviews

1 review(s) available for 2-2-bis(hydroxymethyl)-1-azabicyclo(2-2-2-)octan-3-one and Head-and-Neck-Neoplasms

Article	Year
Strategies for therapeutic targeting of the p53 pathway in cancer. Cell death and differentiation, 2006, Volume: 13, Issue:6 Topics: Adenoviridae; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Mutation; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Viral Vaccines	2006

Article

Year

Strategies for therapeutic targeting of the p53 pathway in cancer.

Cell death and differentiation, 2006, Volume: 13, Issue:6

Topics: Adenoviridae; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Mutation; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Viral Vaccines

2006